Perturbation of p38α MAPK as a Novel Strategy to Effectively Sensitize Chronic Myeloid Leukemia Cells to Therapeutic BCR-ABL Inhibitors

por Kuo, Yi-Hue, Wei, Shih-Hsiang, Jiang, Jie-Hau, Chang, Yueh-Shih, Liu, Mei-Yin, Fu, Shu-Ling, Huang, Chi-Ying F., Lin, Wey-Jinq
Publicado 2021